Cytori Cell Research Institute: Corporate Governance Report as of July 5, 2024.
Cytori Cell Research Institute: Interim report
Cytori Cell Research Institute: Independent Company Executives Declaration
Cytori Cell Research Institute: Internal control report - 20th period (2023/04/01 - 2024/03/31)
Cytori Cell Research Institute: Confirmatory letter.
Cytori Cell Research Institute: Securities Report - 20th Fiscal Year (April 1, 2023 - March 31, 2024)
Cytori Cell Research Institute: Announcements of individual stocks regarding an overview of the evaluation results on the effectiveness of our Board of Directors.
Cytori Cell Research Institute: Announcements of individual stocks regarding the shipment of shareholder benefits.
Cytori Cell Research Institute: Announcement of changes in the representative director.
Cytori Cell Research Institute: 2024 Annual General Meeting of Shareholders materials (excluding items not included in the written request for delivery based on laws and articles of incorporation regarding electronic provision measures)
Cytori Cell Research Institute: Notice of Convening Regular Shareholders' Meeting for the Year 2024.
Cytori Cell Research Institute: Correction Report (Mass Ownership Report/Change Report)
Cytori Cell Research Institute: Change Report
Cytori Cell Research Institute: Change Report
Cytori Cell Research Institute: Interim Report of Corrections
Cytori Cell Research Institute: (Correction) Partial revisions to the “Notice Concerning the Recording of Special Profit, Extraordinary Loss, and Corporate Tax Adjustment Amounts, Differences Between Full-Year Consolidated Earnings Forecasts and Actual Values, and Dividends (No Dividends) from Surplus Funds”
Cytori Cell Research Institute: (Correction/Numerical Data Correction) Partial Corrections to the “Financial Results Summary for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)”
Cytori Cell Research Institute: Extraordinary Report
Cytori Cell Research Institute: Notice regarding the recording of special profit, extraordinary loss, and corporate tax adjustments, differences between full-year consolidated earnings forecasts and actual values, and dividends (no dividends) from surplus
Cytori Cell Research Institute: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
No Data